PRICE T ROWE ASSOCIATES INC /MD/ - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 218 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.17 and the average weighting 0.2%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$695
+6.4%
72,107
+17.5%
0.00%
Q2 2023$653
+3.7%
61,345
+2.6%
0.00%
Q1 2023$630
-45.1%
59,794
-35.5%
0.00%
Q4 2022$1,148
-99.9%
92,695
-7.7%
0.00%
Q3 2022$1,041,000
-1.2%
100,389
+9.8%
0.00%
Q2 2022$1,054,000
-8.5%
91,397
-0.2%
0.00%
Q1 2022$1,152,000
+1.2%
91,550
-6.2%
0.00%
Q4 2021$1,138,000
-28.7%
97,617
-20.1%
0.00%
Q3 2021$1,595,000
-6.7%
122,145
-8.1%
0.00%
Q2 2021$1,710,000
+1.4%
132,845
-12.0%
0.00%
Q1 2021$1,687,000
-14.4%
150,914
-12.8%
0.00%
Q4 2020$1,971,000
-77.2%
173,074
-82.0%
0.00%
-100.0%
Q3 2020$8,637,000
-18.3%
960,158
-6.3%
0.00%0.0%
Q2 2020$10,571,000
-14.6%
1,024,292
-16.5%
0.00%
-50.0%
Q1 2020$12,372,000
-20.3%
1,226,123
+5.1%
0.00%0.0%
Q4 2019$15,530,000
+54.5%
1,166,815
-0.3%
0.00%
+100.0%
Q3 2019$10,052,000
-20.4%
1,170,882
+1.5%
0.00%
-50.0%
Q2 2019$12,625,000
-57.6%
1,154,044
-47.6%
0.00%
-50.0%
Q1 2019$29,791,000
-7.0%
2,201,880
-28.8%
0.00%
-20.0%
Q4 2018$32,025,000
-80.6%
3,091,185
-65.4%
0.01%
-79.2%
Q3 2018$164,737,000
-22.9%
8,923,985
-20.1%
0.02%
-27.3%
Q2 2018$213,543,000
+13.3%
11,168,591
-8.5%
0.03%
+10.0%
Q1 2018$188,407,000
-29.6%
12,210,451
-31.6%
0.03%
-30.2%
Q4 2017$267,777,000
+0.1%
17,863,732
+5.3%
0.04%
-6.5%
Q3 2017$267,467,000
-13.8%
16,960,490
+3.3%
0.05%
-17.9%
Q2 2017$310,124,000
+11.5%
16,426,065
+0.7%
0.06%
+7.7%
Q1 2017$278,190,000
+25.6%
16,306,543
+12.5%
0.05%
+18.2%
Q4 2016$221,538,000
+59.1%
14,489,073
+65.2%
0.04%
+57.1%
Q3 2016$139,282,000
+42.0%
8,770,893
+16.9%
0.03%
+33.3%
Q2 2016$98,083,000
+33.7%
7,501,583
+11.9%
0.02%
+31.2%
Q1 2016$73,355,000
+23.7%
6,705,210
+31.0%
0.02%
+33.3%
Q4 2015$59,318,000
+11.0%
5,118,010
-0.2%
0.01%0.0%
Q3 2015$53,447,000
-14.6%
5,129,310
-1.2%
0.01%
-7.7%
Q2 2015$62,588,000
+48.7%
5,189,700
+97.3%
0.01%
+44.4%
Q1 2015$42,084,000
+183.0%
2,630,248
+171.0%
0.01%
+200.0%
Q4 2014$14,870,000
-19.0%
970,620
-31.5%
0.00%
-25.0%
Q3 2014$18,353,000
-17.2%
1,416,701
-2.1%
0.00%
-20.0%
Q2 2014$22,178,000
-2.5%
1,446,701
-21.7%
0.01%0.0%
Q1 2014$22,752,000
-50.2%
1,846,736
-53.1%
0.01%0.0%
Q4 2013$45,730,000
+126.0%
3,938,908
+130.7%
0.01%0.0%
Q3 2013$20,233,000
-36.9%
1,707,400
-47.0%
0.01%
+25.0%
Q2 2013$32,080,0003,224,2000.00%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Sarissa Capital Management LP 16,390,000$157,835,70021.26%
AlphaCentric Advisors LLC 292,500$2,816,7751.60%
Quantedge Capital Pte Ltd 179,900$1,732,4370.94%
Intrinsic Value Partners, LLC 50,355$484,9190.62%
Brown Capital Management 3,719,796$35,821,6350.55%
ARMISTICE CAPITAL, LLC 3,456,000$33,281,2800.51%
SummerHaven Investment Management, LLC 67,765$652,5770.48%
BRAIDWELL LP 1,348,099$12,982,1930.41%
AFFINITY INVESTMENT ADVISORS, LLC 50,733$488,5590.32%
EMC Capital Management 43,315$4170.31%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders